HealthDay - THURSDAY, Sept. 18 (HealthDay News) -- Men receivinghormone-deprivation therapy for advanced but localized prostate cancer candevelop bone loss as a side effect of the treatment.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.